FDA clears Interpore's bone void filler:
This article was originally published in Clinica
The US FDA has cleared Interpore Cross International's bone void filler, BonePlast. The biocompatible, calcium sulphate-based material that resorbs and is replaced with bone during the healing process may be used in bony voids of the skeletal system, such as the extremities, spine and pelvis. It has a mouldable, dough-like consistency and remains workable for around six to eight minutes before hardening. The Irvine, California-based company plans to begin selling the product later this year.